Insider · CIK 0002023806
Sanam Pangali
Files at ALMS (ALUMIS INC.), SLRN (ACELYRIN, Inc.). First filing Jul 8, 2026, latest Aug 5, 2026.
In brief
Sanam Pangali files SEC Form 4 as officer at ALMS (ALUMIS INC.), and also at SLRN (ACELYRIN, Inc.). Since Jul 8, 2026, Sanam Pangali has reported 0 open-market buys worth $0 and 2 open-market sells worth $176k, the latest filed on Aug 5, 2026.
A track record needs three past buys with six months of prices behind them; Sanam Pangali has 0, so none is measured yet.
The newest scored trade: sold $36k of ALMS on Aug 3, 2026, filed Aug 5, 2026, scored 41 (moderate). In the last 12 months: 0 buys worth $0 and 2 sells worth $176k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ALMS: ALUMIS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 41Moderate | ALUMIS INC. | $36k 1,364 shares | -12% | +561% from low-14% from high | |
| 21Weak | ALMSsell ALUMIS INC. | $140k 5,000 shares | -31% | +724% from low-9% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 6, 2026 | ALMS ALUMIS INC. | 5,000 0.00% of outstanding | $140k | Jul 6, 2026 | none |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 3, 2026 | ALMS ALUMIS INC. | SOpen-market sale Common Stock | -1,364 | $26.37 | $36k | 9,747 | Aug 5, 2026 |
| Jul 6, 2026 | ALMS ALUMIS INC. | MOption exercise Common Stock | +5,000 | $5.06 | $25k | 16,111 | Jul 8, 2026 |
| Jul 6, 2026 | ALMS ALUMIS INC. | SOpen-market sale Common Stock | -5,000 | $28.00 | $140k | 11,111 | Jul 8, 2026 |
| Jul 6, 2026 | ALMS ALUMIS INC. | MOption exercise Stock Option (Right to Buy)derivative | -5,000 | $0.00 | $0 | 36,000 | Jul 8, 2026 |
| Jan 26, 2026 | ALMS ALUMIS INC. | AGrant or award Stock Option (Right to Buy)derivative | +186,200 | $0.00 | $0 | 186,200 | Jan 28, 2026 |
| Jul 29, 2025 | ALMS ALUMIS INC. | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 11,111 | Jul 31, 2025 |
| Jul 29, 2025 | ALMS ALUMIS INC. | AGrant or award Stock Option (Right to Buy)derivative | +40,000 | $0.00 | $0 | 40,000 | Jul 31, 2025 |
| Jul 10, 2025 | ALMS ALUMIS INC. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jul 14, 2025 |
| May 23, 2024 | SLRN ACELYRIN, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +328,860 | $0.00 | $0 | 328,860 | May 24, 2024 |
| May 15, 2024 | SLRN ACELYRIN, Inc. | FTax withholding Common Stock | -921 | $4.47 | $4,117 | 74,154 | May 17, 2024 |
Questions about Sanam Pangali
Answered from the filings on this page, as of the latest one.
Is Sanam Pangali buying or selling?
In the last 12 months Sanam Pangali reported 0 open-market buys worth $0 and 2 open-market sells worth $176k on SEC Form 4; the latest was sold $36k of ALMS on Aug 3, 2026. Grants, option exercises and tax withholding are not counted.
How did Sanam Pangali's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Sanam Pangali has 0.
Where does Sanam Pangali file Form 4?
Sanam Pangali has filed Form 4 at ALMS (ALUMIS INC.) as Chief Legal Officer; SLRN (ACELYRIN, Inc.) as CLO & Head of People. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.